 Huntington Potter
Concepts (342)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 37 | 2022 | 472 | 7.270 |
Why?
| | Amyloid beta-Peptides | 22 | 2022 | 189 | 4.230 |
Why?
| | Electroporation | 8 | 2018 | 30 | 3.300 |
Why?
| | Transfection | 10 | 2018 | 964 | 2.830 |
Why?
| | Cognition Disorders | 13 | 2012 | 594 | 2.280 |
Why?
| | Amyloid beta-Protein Precursor | 14 | 2022 | 59 | 1.900 |
Why?
| | Cognitive Dysfunction | 6 | 2020 | 297 | 1.720 |
Why?
| | Down Syndrome | 7 | 2022 | 341 | 1.540 |
Why?
| | tau Proteins | 4 | 2019 | 69 | 1.510 |
Why?
| | Aneuploidy | 4 | 2017 | 78 | 1.450 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2022 | 159 | 1.340 |
Why?
| | Cognition | 11 | 2022 | 1047 | 1.320 |
Why?
| | Neuropsychological Tests | 14 | 2020 | 1139 | 1.310 |
Why?
| | Chromosome Segregation | 3 | 2013 | 45 | 1.180 |
Why?
| | Apolipoprotein E4 | 3 | 2022 | 32 | 1.060 |
Why?
| | Mice, Transgenic | 19 | 2018 | 2137 | 1.050 |
Why?
| | Neurons | 6 | 2017 | 1448 | 1.020 |
Why?
| | Dementia | 6 | 2012 | 199 | 0.990 |
Why?
| | Apolipoproteins E | 7 | 2019 | 92 | 0.970 |
Why?
| | Spindle Apparatus | 3 | 2013 | 91 | 0.940 |
Why?
| | Immune System | 2 | 2022 | 202 | 0.910 |
Why?
| | Exosomes | 2 | 2020 | 82 | 0.910 |
Why?
| | Caffeine | 4 | 2012 | 66 | 0.830 |
Why?
| | Peptide Fragments | 6 | 2022 | 741 | 0.820 |
Why?
| | Ultracentrifugation | 1 | 2020 | 58 | 0.810 |
Why?
| | Apathy | 1 | 2020 | 7 | 0.810 |
Why?
| | Psychiatric Status Rating Scales | 5 | 2012 | 593 | 0.790 |
Why?
| | Temporal Lobe | 6 | 2012 | 102 | 0.780 |
Why?
| | West Nile Fever | 1 | 2020 | 53 | 0.760 |
Why?
| | Presenilin-1 | 6 | 2016 | 28 | 0.750 |
Why?
| | Hippocampus | 7 | 2022 | 864 | 0.730 |
Why?
| | Animals | 36 | 2022 | 35444 | 0.710 |
Why?
| | Alzheimer Vaccines | 2 | 2008 | 2 | 0.710 |
Why?
| | Mice | 25 | 2022 | 15878 | 0.710 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2017 | 7 | 0.690 |
Why?
| | Brain | 11 | 2014 | 2793 | 0.680 |
Why?
| | Disease Models, Animal | 15 | 2022 | 3893 | 0.680 |
Why?
| | Central Nervous System Stimulants | 3 | 2009 | 148 | 0.670 |
Why?
| | Gene Expression | 5 | 2020 | 1550 | 0.630 |
Why?
| | Uniparental Disomy | 1 | 2016 | 6 | 0.600 |
Why?
| | Nanoparticles | 1 | 2020 | 338 | 0.600 |
Why?
| | alpha 1-Antichymotrypsin | 2 | 2006 | 2 | 0.590 |
Why?
| | Amyloid | 3 | 2021 | 93 | 0.590 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 52 | 0.580 |
Why?
| | Trisomy | 1 | 2016 | 56 | 0.580 |
Why?
| | Atrophy | 8 | 2011 | 154 | 0.560 |
Why?
| | Astrocytes | 3 | 2022 | 170 | 0.550 |
Why?
| | DNA | 3 | 2018 | 1381 | 0.540 |
Why?
| | Proteomics | 1 | 2020 | 810 | 0.540 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 356 | 0.530 |
Why?
| | Coronavirus Infections | 1 | 2020 | 345 | 0.530 |
Why?
| | Receptors, Neurotransmitter | 1 | 2014 | 13 | 0.530 |
Why?
| | Cells, Cultured | 12 | 2020 | 4319 | 0.520 |
Why?
| | Protoplasts | 5 | 2018 | 7 | 0.520 |
Why?
| | Maze Learning | 7 | 2010 | 101 | 0.520 |
Why?
| | Nerve Growth Factors | 1 | 2014 | 76 | 0.510 |
Why?
| | Niemann-Pick Disease, Type C | 1 | 2013 | 2 | 0.500 |
Why?
| | Mitosis | 2 | 2011 | 182 | 0.490 |
Why?
| | Mutation | 6 | 2017 | 3480 | 0.480 |
Why?
| | Humans | 51 | 2022 | 119430 | 0.460 |
Why?
| | Cholesterol, LDL | 1 | 2013 | 321 | 0.430 |
Why?
| | Molecular Motor Proteins | 1 | 2011 | 38 | 0.420 |
Why?
| | Aged | 20 | 2022 | 20621 | 0.410 |
Why?
| | Memory, Episodic | 2 | 2021 | 42 | 0.400 |
Why?
| | Chromosomes, Mammalian | 1 | 2009 | 23 | 0.390 |
Why?
| | Receptors, LDL | 1 | 2010 | 39 | 0.390 |
Why?
| | Neuropharmacology | 1 | 2009 | 4 | 0.390 |
Why?
| | Amyloidosis | 1 | 2010 | 42 | 0.390 |
Why?
| | Infusion Pumps, Implantable | 1 | 2009 | 23 | 0.390 |
Why?
| | Atherosclerosis | 1 | 2013 | 315 | 0.380 |
Why?
| | Plants | 4 | 2018 | 193 | 0.380 |
Why?
| | Disease Progression | 6 | 2012 | 2531 | 0.370 |
Why?
| | Checklist | 1 | 2010 | 77 | 0.370 |
Why?
| | Multicenter Studies as Topic | 1 | 2010 | 239 | 0.370 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 88 | 0.370 |
Why?
| | Apoptosis | 2 | 2017 | 2638 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 9 | 2012 | 3272 | 0.340 |
Why?
| | Aged, 80 and over | 13 | 2021 | 6916 | 0.340 |
Why?
| | Encephalitis | 3 | 2020 | 130 | 0.320 |
Why?
| | Plasma | 1 | 2009 | 246 | 0.310 |
Why?
| | Herpes Zoster | 2 | 2021 | 318 | 0.310 |
Why?
| | Activities of Daily Living | 1 | 2009 | 388 | 0.310 |
Why?
| | Genetic Loci | 2 | 2019 | 245 | 0.290 |
Why?
| | Environment | 3 | 2007 | 416 | 0.290 |
Why?
| | Mice, Inbred C57BL | 7 | 2017 | 5233 | 0.280 |
Why?
| | Memory | 2 | 2020 | 293 | 0.280 |
Why?
| | Intermediate Filament Proteins | 1 | 2004 | 68 | 0.270 |
Why?
| | Dendritic Cells | 1 | 2008 | 493 | 0.270 |
Why?
| | Reproducibility of Results | 5 | 2010 | 2982 | 0.260 |
Why?
| | Genotype | 7 | 2017 | 1878 | 0.250 |
Why?
| | Muscles | 2 | 2017 | 335 | 0.250 |
Why?
| | Algorithms | 2 | 2012 | 1555 | 0.240 |
Why?
| | Imipramine | 1 | 2022 | 12 | 0.240 |
Why?
| | Cytokines | 4 | 2022 | 1992 | 0.230 |
Why?
| | Female | 23 | 2021 | 64501 | 0.230 |
Why?
| | Plant Cells | 3 | 2010 | 8 | 0.230 |
Why?
| | Analysis of Variance | 4 | 2010 | 1512 | 0.230 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 358 | 0.230 |
Why?
| | Predictive Value of Tests | 4 | 2011 | 2006 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 5 | 2019 | 2243 | 0.220 |
Why?
| | Polymerization | 1 | 2022 | 127 | 0.220 |
Why?
| | Cell Line | 3 | 2017 | 2936 | 0.220 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2022 | 138 | 0.220 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 950 | 0.220 |
Why?
| | Catalysis | 1 | 2022 | 307 | 0.220 |
Why?
| | Interneurons | 1 | 2022 | 95 | 0.210 |
Why?
| | Gliosis | 1 | 2021 | 27 | 0.210 |
Why?
| | Arteritis | 1 | 2021 | 30 | 0.210 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 890 | 0.210 |
Why?
| | Healthy Aging | 1 | 2021 | 20 | 0.210 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2021 | 88 | 0.210 |
Why?
| | Chemical Precipitation | 1 | 2020 | 45 | 0.210 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 18 | 0.200 |
Why?
| | Cerebral Cortex | 1 | 2004 | 517 | 0.200 |
Why?
| | Varicella Zoster Virus Infection | 1 | 2020 | 22 | 0.200 |
Why?
| | Plaque, Amyloid | 3 | 2011 | 16 | 0.190 |
Why?
| | Homozygote | 2 | 2017 | 196 | 0.190 |
Why?
| | Skin | 2 | 2017 | 686 | 0.190 |
Why?
| | Male | 20 | 2021 | 61818 | 0.190 |
Why?
| | Gene Dosage | 2 | 2017 | 136 | 0.190 |
Why?
| | Early Diagnosis | 2 | 2011 | 253 | 0.190 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 387 | 0.190 |
Why?
| | Case-Control Studies | 6 | 2020 | 3335 | 0.180 |
Why?
| | White Matter | 1 | 2021 | 108 | 0.180 |
Why?
| | Epitope Mapping | 2 | 2008 | 54 | 0.170 |
Why?
| | Immunity | 1 | 2019 | 134 | 0.170 |
Why?
| | Gene Knock-In Techniques | 1 | 2018 | 45 | 0.170 |
Why?
| | Thiones | 2 | 2016 | 16 | 0.170 |
Why?
| | Brain Mapping | 2 | 2012 | 627 | 0.170 |
Why?
| | Phospholipase C gamma | 1 | 2017 | 26 | 0.170 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 121 | 0.160 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2009 | 88 | 0.160 |
Why?
| | Phosphodiesterase Inhibitors | 2 | 2009 | 96 | 0.160 |
Why?
| | Heterozygote | 1 | 2017 | 256 | 0.160 |
Why?
| | Blotting, Western | 3 | 2011 | 1295 | 0.160 |
Why?
| | Calcium | 2 | 2014 | 1235 | 0.160 |
Why?
| | Betacoronavirus | 1 | 2020 | 263 | 0.160 |
Why?
| | Attention | 1 | 2020 | 474 | 0.150 |
Why?
| | Lithium Chloride | 1 | 2016 | 16 | 0.150 |
Why?
| | Transgenes | 1 | 2017 | 194 | 0.150 |
Why?
| | Mammals | 2 | 2011 | 219 | 0.150 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 208 | 0.150 |
Why?
| | Long-Term Potentiation | 2 | 2016 | 156 | 0.150 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2016 | 30 | 0.150 |
Why?
| | Mosaicism | 1 | 2016 | 57 | 0.140 |
Why?
| | Dendritic Spines | 1 | 2016 | 56 | 0.140 |
Why?
| | Executive Function | 1 | 2020 | 400 | 0.140 |
Why?
| | Functional Laterality | 3 | 2012 | 250 | 0.140 |
Why?
| | Genome-Wide Association Study | 3 | 2019 | 1024 | 0.140 |
Why?
| | Mice, Inbred BALB C | 2 | 2008 | 1328 | 0.140 |
Why?
| | Microglia | 1 | 2017 | 255 | 0.140 |
Why?
| | Lipids | 1 | 2019 | 638 | 0.140 |
Why?
| | Membrane Glycoproteins | 1 | 2017 | 497 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2017 | 1803 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2017 | 392 | 0.130 |
Why?
| | PC12 Cells | 1 | 2014 | 43 | 0.130 |
Why?
| | Biomarkers | 3 | 2022 | 3593 | 0.130 |
Why?
| | Pyrimidines | 2 | 2016 | 414 | 0.130 |
Why?
| | Nerve Growth Factor | 1 | 2014 | 34 | 0.130 |
Why?
| | Neurites | 1 | 2014 | 36 | 0.130 |
Why?
| | Amnesia | 2 | 2012 | 40 | 0.130 |
Why?
| | Middle Aged | 10 | 2021 | 29262 | 0.130 |
Why?
| | Membrane Fluidity | 1 | 2013 | 13 | 0.130 |
Why?
| | Anxiety | 1 | 2020 | 877 | 0.120 |
Why?
| | Risk Factors | 6 | 2014 | 9298 | 0.120 |
Why?
| | Pancreatitis, Alcoholic | 1 | 2012 | 2 | 0.120 |
Why?
| | Trypsinogen | 1 | 2012 | 20 | 0.120 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1803 | 0.120 |
Why?
| | Claudins | 1 | 2012 | 22 | 0.120 |
Why?
| | Trypsin | 1 | 2012 | 75 | 0.120 |
Why?
| | Cell Cycle | 1 | 2016 | 596 | 0.120 |
Why?
| | Pandemics | 1 | 2020 | 1133 | 0.110 |
Why?
| | Memory Disorders | 2 | 2012 | 192 | 0.110 |
Why?
| | Glutamic Acid | 1 | 2014 | 228 | 0.110 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 247 | 0.110 |
Why?
| | Neuroglia | 1 | 2013 | 192 | 0.110 |
Why?
| | Brain Chemistry | 1 | 2012 | 155 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2016 | 943 | 0.110 |
Why?
| | Centrosome | 1 | 2011 | 63 | 0.110 |
Why?
| | Parkinsonian Disorders | 1 | 2011 | 30 | 0.110 |
Why?
| | Neuronal Plasticity | 1 | 2014 | 237 | 0.110 |
Why?
| | Entorhinal Cortex | 1 | 2011 | 13 | 0.110 |
Why?
| | Longitudinal Studies | 4 | 2012 | 2737 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2017 | 754 | 0.110 |
Why?
| | Follow-Up Studies | 2 | 2011 | 4998 | 0.110 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2013 | 242 | 0.100 |
Why?
| | Mice, Knockout | 2 | 2010 | 2863 | 0.100 |
Why?
| | Vaccines, DNA | 1 | 2010 | 29 | 0.100 |
Why?
| | Age Factors | 2 | 2009 | 3299 | 0.100 |
Why?
| | Inflammation | 1 | 2022 | 2564 | 0.100 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 382 | 0.100 |
Why?
| | Xenopus | 1 | 2011 | 130 | 0.100 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 2010 | 20 | 0.100 |
Why?
| | Oocytes | 1 | 2011 | 216 | 0.100 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2010 | 81 | 0.100 |
Why?
| | Florida | 1 | 2009 | 85 | 0.090 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2009 | 42 | 0.090 |
Why?
| | Neuroimaging | 1 | 2011 | 238 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2009 | 48 | 0.090 |
Why?
| | Homeostasis | 1 | 2013 | 599 | 0.090 |
Why?
| | Observer Variation | 1 | 2010 | 342 | 0.090 |
Why?
| | Theophylline | 1 | 2009 | 58 | 0.090 |
Why?
| | Microdialysis | 1 | 2009 | 97 | 0.090 |
Why?
| | Tubulin | 1 | 2010 | 127 | 0.090 |
Why?
| | Geriatric Assessment | 1 | 2010 | 183 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2010 | 268 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2009 | 165 | 0.090 |
Why?
| | Drug Synergism | 1 | 2009 | 360 | 0.090 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2009 | 343 | 0.090 |
Why?
| | Antibody Specificity | 1 | 2008 | 193 | 0.090 |
Why?
| | Fibroblasts | 1 | 2013 | 887 | 0.090 |
Why?
| | Drug Interactions | 1 | 2009 | 401 | 0.080 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 142 | 0.080 |
Why?
| | Psychomotor Performance | 2 | 2009 | 345 | 0.080 |
Why?
| | Ethanol | 1 | 2013 | 743 | 0.080 |
Why?
| | Cross Reactions | 1 | 2008 | 167 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2011 | 574 | 0.080 |
Why?
| | Blood | 1 | 2007 | 103 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2022 | 12359 | 0.080 |
Why?
| | Genetic Variation | 1 | 2012 | 851 | 0.080 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2007 | 61 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 318 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2011 | 1427 | 0.080 |
Why?
| | t-Complex Genome Region | 1 | 2006 | 3 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1090 | 0.080 |
Why?
| | Supranuclear Palsy, Progressive | 1 | 2006 | 6 | 0.080 |
Why?
| | Bone Marrow | 1 | 2008 | 260 | 0.080 |
Why?
| | Time Factors | 2 | 2009 | 7096 | 0.080 |
Why?
| | Exploratory Behavior | 1 | 2007 | 114 | 0.080 |
Why?
| | Rolipram | 1 | 2006 | 4 | 0.080 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2006 | 88 | 0.080 |
Why?
| | Antibody Formation | 1 | 2008 | 311 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 1 | 2006 | 138 | 0.080 |
Why?
| | Silver Staining | 1 | 2006 | 21 | 0.080 |
Why?
| | Valine | 1 | 2006 | 89 | 0.080 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 812 | 0.080 |
Why?
| | Aging | 2 | 2009 | 1740 | 0.080 |
Why?
| | Methionine | 1 | 2006 | 158 | 0.070 |
Why?
| | Problem Solving | 1 | 2007 | 163 | 0.070 |
Why?
| | Phosphorylation | 2 | 2011 | 1754 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 943 | 0.070 |
Why?
| | Immunologic Memory | 1 | 2008 | 304 | 0.070 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 173 | 0.070 |
Why?
| | Superoxide Dismutase | 1 | 2007 | 343 | 0.070 |
Why?
| | Microtubule-Associated Proteins | 1 | 2006 | 199 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2878 | 0.070 |
Why?
| | Behavior, Animal | 2 | 2006 | 625 | 0.070 |
Why?
| | Lysine | 1 | 2006 | 236 | 0.070 |
Why?
| | Benzothiazoles | 1 | 2004 | 42 | 0.070 |
Why?
| | Spinal Cord | 1 | 2007 | 407 | 0.070 |
Why?
| | Spleen | 1 | 2006 | 538 | 0.070 |
Why?
| | Genetics, Behavioral | 1 | 2004 | 72 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2008 | 1169 | 0.070 |
Why?
| | Rats | 1 | 2014 | 6279 | 0.070 |
Why?
| | Thiazoles | 1 | 2004 | 119 | 0.060 |
Why?
| | Gene Frequency | 2 | 2017 | 436 | 0.060 |
Why?
| | Peptides | 1 | 2009 | 886 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 781 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2197 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 833 | 0.060 |
Why?
| | Memory, Short-Term | 1 | 2006 | 275 | 0.060 |
Why?
| | Indicators and Reagents | 1 | 2003 | 106 | 0.060 |
Why?
| | Growth Disorders | 1 | 2022 | 84 | 0.060 |
Why?
| | Pregnancy | 1 | 2014 | 5571 | 0.060 |
Why?
| | Prognosis | 1 | 2010 | 3587 | 0.050 |
Why?
| | Nuclear Proteins | 1 | 2006 | 640 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2010 | 2870 | 0.050 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 294 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2021 | 286 | 0.050 |
Why?
| | Models, Biological | 1 | 2009 | 1815 | 0.050 |
Why?
| | Intracellular Space | 1 | 2020 | 81 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2008 | 1835 | 0.050 |
Why?
| | Extracellular Space | 1 | 2020 | 138 | 0.050 |
Why?
| | Acyclovir | 1 | 2020 | 111 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 86 | 0.050 |
Why?
| | Protein Aggregates | 1 | 2020 | 102 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4623 | 0.040 |
Why?
| | Child, Preschool | 1 | 2013 | 9898 | 0.040 |
Why?
| | DNA, Viral | 1 | 2021 | 430 | 0.040 |
Why?
| | Adult | 3 | 2020 | 32835 | 0.040 |
Why?
| | Protein Interaction Maps | 1 | 2017 | 35 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2010 | 4923 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2022 | 531 | 0.040 |
Why?
| | Haplotypes | 1 | 2019 | 421 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2012 | 749 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 319 | 0.040 |
Why?
| | Cell Membrane | 1 | 2001 | 752 | 0.040 |
Why?
| | Young Adult | 1 | 2013 | 11188 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2017 | 261 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2017 | 391 | 0.040 |
Why?
| | Exome | 1 | 2017 | 159 | 0.040 |
Why?
| | Discriminant Analysis | 2 | 2007 | 50 | 0.040 |
Why?
| | Genetic Testing | 1 | 2019 | 376 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2576 | 0.040 |
Why?
| | Long-Term Synaptic Depression | 1 | 2016 | 43 | 0.040 |
Why?
| | Sweden | 1 | 2015 | 61 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2019 | 531 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 97 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 1069 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 662 | 0.030 |
Why?
| | Child | 1 | 2013 | 18852 | 0.030 |
Why?
| | Pedigree | 1 | 2015 | 477 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1236 | 0.030 |
Why?
| | Drug Discovery | 1 | 2014 | 139 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2014 | 202 | 0.030 |
Why?
| | Age of Onset | 1 | 2014 | 482 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2017 | 2159 | 0.030 |
Why?
| | Stroke | 1 | 2021 | 1005 | 0.030 |
Why?
| | Autopsy | 1 | 2012 | 102 | 0.030 |
Why?
| | Kinetics | 1 | 2016 | 1766 | 0.030 |
Why?
| | Threonine | 1 | 2011 | 52 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2011 | 176 | 0.030 |
Why?
| | ROC Curve | 1 | 2012 | 499 | 0.030 |
Why?
| | Reference Values | 1 | 2012 | 862 | 0.030 |
Why?
| | Motor Activity | 2 | 2007 | 763 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1591 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2011 | 365 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1022 | 0.020 |
Why?
| | Alleles | 1 | 2012 | 786 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 895 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 605 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2011 | 427 | 0.020 |
Why?
| | Superoxide Dismutase-1 | 1 | 2007 | 15 | 0.020 |
Why?
| | Mice, Neurologic Mutants | 1 | 2007 | 23 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1433 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 1993 | 0.020 |
Why?
| | Random Allocation | 1 | 2007 | 400 | 0.020 |
Why?
| | RNA | 1 | 2012 | 807 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 309 | 0.020 |
Why?
| | Corticosterone | 1 | 2007 | 308 | 0.020 |
Why?
| | Motor Neurons | 1 | 2007 | 217 | 0.020 |
Why?
| | Social Environment | 1 | 2007 | 374 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1227 | 0.020 |
Why?
| | Synapses | 1 | 2007 | 337 | 0.020 |
Why?
| | Space Perception | 1 | 2004 | 78 | 0.020 |
Why?
| | Avoidance Learning | 1 | 2004 | 92 | 0.020 |
Why?
| | Factor Analysis, Statistical | 1 | 2004 | 308 | 0.020 |
Why?
| | Prospective Studies | 1 | 2014 | 6605 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2004 | 343 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 1138 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 1750 | 0.010 |
Why?
| | United States | 1 | 2015 | 12946 | 0.010 |
Why?
|
|
Potter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|